Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Chlorpromazine and Standard of Care in Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
- Status
- RECRUITING
- Phase
- PHASE1
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
- Status
- RECRUITING
- Phase
- PHASE1
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
- Status
- RECRUITING
- Phase
- PHASE2
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2